Thank you, Yisca, and thank you all for joining us today. Cloud security remained a key growth driver in the third quarter ...
The use of IL-1 alpha and beta inhibition with ARCALYST has increasingly become the preferred treatment for recurrent ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile
Părere